Active substance
Results for the substance ribavirin+interferon alfa 2b
1 result
About this active substance
The combination of ribavirin and interferon alfa-2B is used for the treatment of chronic hepatitis C. Ribavirin inhibits viral replication, while interferon alfa-2B enhances the body's immune response against the virus.
The medication is administered orally (ribavirin) and by injection (interferon alfa-2B), as directed by a doctor. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the therapy's effectiveness and side effects.
Patients should be aware of potential side effects, such as anemia, fatigue, flu-like symptoms, or depression. It is important to inform the doctor of any unusual symptoms.
Common side effects include anemia, fatigue, flu-like symptoms, and skin irritation. In rare cases, severe reactions such as severe depression or liver dysfunction may occur. Patients should be informed of these risks before use.
The medication is administered orally (ribavirin) and by injection (interferon alfa-2B), as directed by a doctor. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the therapy's effectiveness and side effects.
Patients should be aware of potential side effects, such as anemia, fatigue, flu-like symptoms, or depression. It is important to inform the doctor of any unusual symptoms.
Common side effects include anemia, fatigue, flu-like symptoms, and skin irritation. In rare cases, severe reactions such as severe depression or liver dysfunction may occur. Patients should be informed of these risks before use.